Open AccessDrug-Resistant HIV Infection among Drug-Naive Patients in Israel
Author(s) -
Zehava Grossman,
Margalit Lorber,
Shlomo Maayan,
Niva Yacov,
Itzchak Levy,
Diana Averbuch,
Valery Istomin,
Michal Chowers,
Zev Sthoeger,
Daniel R. Ram,
H Rudich,
Fernando Mileguir,
Radu Pavel,
R. Almaliach,
F. Schlaeffer,
Zipi Kra Oz,
Ella Mendelson,
Jonathan Schapiro,
Klaris Riesenberg
Publication year - 2004
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/426592
Subject(s) - reverse transcriptase , virology , medicine , drug resistance , resistance mutation , virus , population , transmission (telecommunications) , protease , lentivirus , sida , viral disease , immunology , biology , polymerase chain reaction , microbiology and biotechnology , enzyme , genetics , gene , biochemistry , electrical engineering , environmental health , engineering
In Israel, <0.06% of the general population is infected with human immunodeficiency virus (HIV), with a much higher prevalence among specific groups. These groups are distinguished demographically by risk behavior category and by virus subtype. We investigated transmission of drug resistance within groups to assess the impact of these factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom